共查询到18条相似文献，搜索用时 343 毫秒
1.
2.
造血干细胞(hematopoietic stem cell, HSC)位于造血系统的顶端, 是造血系统中唯一具有多能性和自我更新能力的细胞, 可以分化为各种功能的血细胞, 维持血液系统的建立和动态平衡, 是目前研究最为透彻、临床应用最为成熟的成体干细胞。造血干细胞的这些重要特性, 使得基于造血干细胞在治病机制研究和临床应用中的研究取得了很大进展。以造血干细胞为基础的再生医学治疗是目前治疗恶性血液病和遗传病的首选方法, 如造血干细胞治疗犬白细胞黏附缺陷综合征、犬遗传性贫血、犬淋巴瘤、犬白细胞减少症、犬X连锁严重联合免疫缺陷病等, 但由于白细胞抗原匹配的供体稀缺、可获得的造血干细胞数量有限等原因, 无法满足临床需求, 因此, 如何通过体外培养获得满足临床需要的造血干细胞成为近年来学者们研究的热点问题。作者参照现有研究成果对造血干细胞的来源和体外分离培养、治病机制进行系统的描述, 并对造血干细胞移植治疗遗传性溶血性贫血、白细胞黏附缺陷综合征、淋巴瘤、白细胞减少症、X连锁严重联合免疫缺陷病的临床研究进行综述, 以期为今后将造血干细胞广泛应用于临床治疗提供参考依据。 相似文献
3.
4.
骨髓间充质干细胞的研究进展 总被引：1，自引：0，他引：1
骨髓间充质干细胞是存在于骨髓中的除造血干细胞以外的另一类具有多向分化潜能的干细胞。在一定的诱导条件下 ,这类细胞可定向分化为多种造血以外组织 ,特别是中胚层和神经外胚层来源的组织细胞。例如成骨细胞、成软骨细胞、脂肪细胞、腱细胞、肌肉细胞、神经细胞等。骨髓间充质干细胞具有贴壁生长的特性 ,在体外易分离和扩增 ,还易于外源基因的转入和表达 ,在人类医学上被认为是一种理想的治疗性细胞和基因治疗中的靶细胞。本文针对骨髓间充质干细胞的研究进展和在临床医学上的应用进行综述 相似文献
5.
6.
7.
8.
9.
<正> 凡需要不断产生新的分化细胞以及分化细胞本身不能分裂的组织都存在有干细胞(stem cell),比如,存在于造血系统中的干细胞能分化成红细胞、血小板、淋巴细胞;表皮的基底细胞能分化出上皮细胞;精原细胞能分化出精细胞;嗅上皮基底细胞能分化出嗅神经细胞.干细胞的职能不是去执行已分化细胞的功能,而是去产生具有分化功能的细胞.干细胞有两种类型:一种是只能形成一种分化类型的干细胞称做单能(unipotent)干细胞;一种是能够形成一种以上分化类型的干细胞叫多能(pluripotent)干细胞。干细胞有以下几个主要的生物学特性: 相似文献
10.
《黑龙江畜牧兽医》2014,(11)
为了验证联合应用两种干细胞治疗肝硬化疾病的有效性,试验采用贴壁培养法分离小鼠骨髓间充质干细胞,并在体外单克隆纯化,采用免疫磁珠法分离脐带血造血干细胞,对造血干细胞进行无血清培养及生物学性状检测,然后用间充质干细胞联合造血干细胞附加肝细胞生长因子治疗Babl/c裸鼠肝硬化。结果表明:成功纯化培养小鼠骨髓间充质干细胞,体外无血清培养获得脐带血造血干细胞;肝细胞生长因子40 ng/mL、间充质干细胞5×106个、造血干细胞5×106个组作用于Babl/c裸鼠肝硬化模型,Babl/c裸鼠肝功能显著改善,丙氨酸转氨酶由198 U/L下降至86 U/L,天冬氨酸转氨酶由398.7 U/L下降至288.6 U/L。说明小鼠骨髓间充质干细胞能够在体外实现单克隆纯化,小鼠脐带血造血干细胞可以在体外无血清培养并大量克隆,干细胞对肝硬化疾病具有明显的治疗效果。 相似文献
11.
Extramedullary hematopoiesis (EMH) is the formation and development of blood cells outside the medullary spaces of the bone marrow. Although widely considered an epiphenomenon, secondary to underlying primary disease and lacking serious clinical or diagnostic implications, the presence of EMH is far from incidental on a molecular basis; rather, it reflects a well-choreographed suite of changes involving stem cells and their microenvironment (the stem cell niche). The goals of this review are to reconsider the molecular basis of EMH based on current knowledge of stem cell niches and to examine its role in the pathophysiologic mechanisms of EMH in animals. The ability of blood cells to home, proliferate, and mature in extramedullary tissues of adult animals reflects embryonic patterns of hematopoiesis and establishment or reactivation of a stem cell niche. This involves pathophysiologic alterations in hematopoietic stem cells, extracellular matrix, stromal cells, and local and systemic chemokines. Four major theories involving changes in stem cells and/or their microenvironment can explain the development of most occurrences of EMH: (1) severe bone marrow failure; (2) myelostimulation; (3) tissue inflammation, injury, and repair; and (4) abnormal chemokine production. EMH has also been reported within many types of neoplasms. Understanding the concepts and factors involved in stem cell niches enhances our understanding of the occurrence of EMH in animals and its relationship to underlying disease. In turn, a better understanding of the prevalence and distribution of EMH in animals and its molecular basis could further inform our understanding of the hematopoietic stem cell niche. 相似文献
12.
13.
Pablo Gómez-Ochoa Francisco Javier Miana-Mena María Jesús Mu?oz Encarna Cativiela Francisco Gómez 《Canadian journal of veterinary research》2005,69(4):309-312
The purpose of this study was to isolate and cultivate a subpopulation of pluripotent stem cells (PSCs) from the peripheral blood of rabbits, which are frequently used in veterinary research as an animal model. Pluripotent stem cells, as described in human beings, are fibroblast-like cells that exhibit a CD34 marker, specific from other hematopoietic stem cells. Commonly used human commercial media has been researched for culturing rabbit PSCs. These findings allow us to contemplate the direct application of this simple and standardized methodology in several areas of study, such as of the pharmacological effect of many drugs on hematopoietic cells, veterinary practice, and even the study of new strategies in cellular therapy for some human diseases. 相似文献
14.
Zorn J Schwamberger S Panzer W Adler H Kolb HJ 《Veterinary immunology and immunopathology》2011,144(1-2):27-35
Human leukocyte antigen (HLA)-haploidentical stem cell transplantation is an opportunity for nearly all patients lacking an HLA matched stem cell donor. However, graft rejection and graft-versus-host disease (GvHD) as well as infectious complications still result in high treatment-related mortality. Here, we used the dog as a preclinical model for the study of tolerance induction with the aim to optimize and to improve a clinical protocol of haploidentical stem cell transplantation. For this purpose CD6-depleted peripheral blood stem cells (PBSCs) were transfused 6d after transplantation of unmodified bone marrow from dog leukocyte antigen (DLA)-haploidentical littermate donors in order to induce immune tolerance. Besides hematopoietic stem cells CD6-depleted PBSC contain, NK cells and a minority of suppressive CD8-positive cells that may suppress activated T lymphocytes. Recipients were conditioned with, cyclophosphamide and antithymocyte globulin (ATG) preceded by a transfusion of donor buffy coat and either 1, 2 or 3 × 3.3 Gy total body irradiation (TBI). Postgrafting immunosuppression was limited to 30 d of cyclosporine and methotrexate. The additional administration of CD6-depleted PBSCs after unmodified marrow could not prevent GvHD, but it may improve engraftment and chimerism after conditioning with 2 × 3.3 Gy TBI. Reasons for incomplete suppression and possible improvements for clinical applications are discussed. 相似文献
15.
Karyotype analysis of bone marrow cells was performed from 6 Beagles that had received sex-mismatched fetal liver hematopoietic stem cell grafts 2.4 to 6.5 years earlier. Two dogs received dog leukocyte antigen-matched fetal liver cells and 4 received dog leukocyte antigen-mismatched cells. In each dog, all 25 evaluated metaphase spreads were of donor genotype. All dogs had normal hemograms and repopulation of bone marrow and no dog developed graft-vs-host disease. 相似文献
16.
18.
Weiss DJ 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》2005,19(2):147-154
Dysmyelopoiesis is defined as a hematologic disorder characterized by the presence of cytopenias in the blood and dysplastic cells in one or more hematologic cell lines in the blood or bone marrow. The causes of dysmyelopoiesis include acquired mutations in hematopoietic stem cells (i.e., myelodysplastic syndromes [MDSs]), congenital defects in hematopoiesis, and dysmyelopoietic conditions associated with various disease processes, drug treatments, or toxin exposure. Two major subtypes of MDSs (i.e., MDS with refractory cytopenias and MDS with excess myeloblasts) have been described that differ in clinical presentation, response to treatment, and survival time. The most frequently occurring causes of secondary dysmyelopoiesis include immune-mediated hematologic diseases, lymphoid malignancies, and exposure to chemotherapeutic drugs. Differentiation of the various causes of dysmyelopoiesis is essential for establishing an appropriate therapeutic plan and for determining prognosis. 相似文献